A study of 132 childhood cancer survivors found that nearly half experience symptoms of depression or anxiety as adults, highlighting a need for improved long-term follow-up care.
Key facts
- •The study surveyed 132 childhood cancer survivors between the ages of 18 and 40.
- •43% of participants reported significant fatigue, while 28% experienced cognitive difficulties.
- •The prevalence of depression and anxiety in the study group was substantially higher than in the general Norwegian population.
- •Researchers believe chemotherapy and the interruption of normal social development during treatment contribute to adult mental health issues.
- •Experts are calling for lifelong follow-up care for survivors, citing models in places like Sydney, Australia.
A recent study conducted by researchers at NTNU and hospitals in Oslo and Trondheim reveals that adults who survived childhood cancer face significantly higher rates of mental health challenges. Among 132 participants aged 18 to 40, 49% reported clinical symptoms of depression and 41% reported symptoms of anxiety. Researchers suggest that the intensive, two-year treatment period required for survival during early childhood development may contribute to these long-term psychological and cognitive difficulties.
By the numbers
Impact of Early Treatment
The study indicates that the prolonged hospital stays and intensive chemotherapy required to treat childhood cancer—most commonly acute leukemia—can disrupt critical developmental stages. During these two years of treatment, children often miss opportunities to build social, mental, and cognitive skills through school and play. Researchers noted that 28% of participants reported clinically relevant difficulties with cognitive functions, including concentration, planning, and task completion, which may further increase vulnerability to emotional distress.
Need for Specialized Follow-up
Currently, follow-up care for childhood cancer survivors in Norway typically ends when patients turn 18. Associate Professor Magnus Aasved Hjort and medical student Anna Franzén argue that this transition leaves a gap in support. They advocate for the establishment of dedicated late-effects clinics to provide lifelong monitoring, similar to models used in other countries, to help survivors manage these challenges and participate fully in society.
Advertisement
This article was independently rewritten by ManyPress editorial AI from reporting originally published by Medical Xpress.
